@article {488,
	title = {Marginal keratitis associated with administration of filgrastim and sargramostim in a healthy peripheral blood progenitor cell donor},
	journal = {Cornea},
	volume = {21},
	year = {2002},
	note = {HPC Using Smart Source Parsing Aug},
	pages = {621 - 2},
	abstract = {PURPOSE: To describe a 61-year-old healthy peripheral blood progenitor cell (PBPC) donor who developed marginal keratitis and mild uveitis on the third day after receiving daily recombinant human granulocyte colony-stimulating factor (rhG-CSF; filgrastim) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF; sargramostim) to mobilize PBPCs for allogeneic transplantation. METHODS: Interventional case report. RESULTS: The keratitis was treated with topical administration of 1\% prednisolone acetate solution and resolved within 24 hours. The topical steroid dose was tapered and ultimately discontinued without recurrence of keratitis. CONCLUSION: Healthy PBPC donors receiving rhG-CSF or rhGM-CSF should be monitored for ocular complications, particularly marginal keratitis and uveitis.},
	author = {Esmaeli,B. and Ahmadi,M. A. and Kim,S. and Onan,H. and Korbling,M. and Anderlini,P.}
}
